Gene Expression Profiling with DNA Microarrays: Advancing Our Understanding of Psychiatric Disorders
- 1 January 2002
- journal article
- review article
- Published by Springer Nature in Neurochemical Research
- Vol. 27 (10) , 1049-1063
- https://doi.org/10.1023/a:1020904821237
Abstract
DNA microarray transcriptome profiling of the postmortem brain opens novel horizons in understanding molecular changes associated with complex psychiatric disorders. With careful analysis and interpretation of microarray data we are uncovering previously unknown, expression patterns that maybe subject-specific and pivotal in understanding the disease process. In our recent studies, analyses of the prefrontal cortex of subjects with schizophrenia and matched controls uncovered complex changes in the expression of genes related to presynaptic secretory release, GABAergic and glutamatergic transmission, metabolic pathways, myelination, as well as cAMP and phosphoinositol second messenger systems. Our goal will be to integrate this expression data within the context of the relevant anatomical, biochemical, molecular, imaging and clinical findings.Keywords
This publication has 100 references indexed in Scilit:
- Gene expression profiling in the post-mortem human brain — no cause for dismayJournal of Chemical Neuroanatomy, 2001
- Up-Regulation of Calcineurin Aβ mRNA in the Alzheimer's Disease Brain: Assessment by cDNA MicroarrayBiochemical and Biophysical Research Communications, 2001
- A comparison of microarray databasesBriefings in Bioinformatics, 2001
- Exploring the new world of the genome with DNA microarraysNature Genetics, 1999
- Molecular interactions on microarraysNature Genetics, 1999
- Klinefelter's syndrome as a model of anomalous cerebral laterality: Testing gene dosage in the X chromosome pseudoautosomal region using a DNA microarrayDevelopmental Genetics, 1998
- Changes in protein kinase C and adenylate cyclase in the temporal lobe from subjects with schizophreniaJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1997
- Drug Treatment of Schizophrenia in the 1990sDrugs, 1997
- The GTPase-activating Protein RGS4 Stabilizes the Transition State for Nucleotide HydrolysisPublished by Elsevier ,1996
- Increase in [3H]cAMP binding sites and decrease in Giα and Goα immunoreactivities in left temporal cortices from patients with schizophreniaBrain Research, 1993